Delivery Order SPE2DB24D9238-SPE2DB25FDQLL
Award Date
1/24/25
Potential Completion Date
2/14/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $9,736.39 from the Defense Logistics Agency (DLA). The award covers the delivery of OCALIVA 10 MG TABLET 30S, a specialized pharmaceutical product, with an ultimate completion date of March 28, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription...
This federal contract award, valued at $17,497.94, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the delivery of OCALIVA 5 MG TABLET 30S, a pharmaceutical product, under a firm fixed-price delivery order contract. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November...
This federal contract award, valued at $8,751.19, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the drug OCALIVA 10 MG TABLET 30S, with a period of performance through December 27, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award, valued at $26,249.13, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of OCALIVA 5 MG TABLET 30S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,751.19 firm fixed-price contract is for the supply of a specialty pharmaceutical product, OCALIVA 10 MG TABLET 30S, with a period of performance through December 16, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,551.37 firm fixed-price delivery order covers the supply of the pharmaceutical product OCALIVA 5 MG TABLET 30S, with a performance period ending on June 14, 2022. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,320.10 firm fixed-price delivery order is for the supply of OCALIVA 5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $17,497.94 firm fixed-price delivery order is for the provision of 4566758775 - OCALIVA 5 MG TABLET 30S, a specialized pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA). The $26,253.57 firm fixed-price order is for the pharmaceutical product OCALIVA 10 MG TABLET 30S, with a completion date of December 23, 2024. The SPE2DB IDC, valued at $499,999,999 and valid through November 2026, enables the DLA to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,502.38 firm fixed-price delivery order is for the supply of 4566659367 - OCALIVA 10 MG TABLET 30S. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award. DMS...